POPULARITY
Categories
197 episodes with Imaging
72 episodes with Imaging
46 episodes with Imaging
76 episodes with Imaging
41 episodes with Imaging
64 episodes with Imaging
63 episodes with Imaging
27 episodes with Imaging
31 episodes with Imaging
51 episodes with Imaging
19 episodes with Imaging
13 episodes with Imaging
30 episodes with Imaging
20 episodes with Imaging
17 episodes with Imaging
23 episodes with Imaging
23 episodes with Imaging
29 episodes with Imaging
12 episodes with Imaging
15 episodes with Imaging
23 episodes with Imaging
10 episodes with Imaging
21 episodes with Imaging
15 episodes with Imaging
17 episodes with Imaging
70 episodes with Imaging
15 episodes with Imaging
17 episodes with Imaging
14 episodes with Imaging
10 episodes with Imaging
7 episodes with Imaging
17 episodes with Imaging
8 episodes with Imaging
13 episodes with Imaging
7 episodes with Imaging
6 episodes with Imaging
7 episodes with Imaging
8 episodes with Imaging
7 episodes with Imaging
10 episodes with Imaging
28 episodes with Imaging
10 episodes with Imaging
7 episodes with Imaging
6 episodes with Imaging
5 episodes with Imaging
9 episodes with Imaging
10 episodes with Imaging
7 episodes with Imaging
6 episodes with Imaging
11 episodes with Imaging
8 episodes with Imaging
8 episodes with Imaging
10 episodes with Imaging
23 episodes with Imaging
6 episodes with Imaging
7 episodes with Imaging
8 episodes with Imaging
8 episodes with Imaging
6 episodes with Imaging
8 episodes with Imaging
14 episodes with Imaging
16 episodes with Imaging
6 episodes with Imaging
7 episodes with Imaging
6 episodes with Imaging
15 episodes with Imaging
4 episodes with Imaging
6 episodes with Imaging
7 episodes with Imaging
11 episodes with Imaging
7 episodes with Imaging
7 episodes with Imaging
5 episodes with Imaging
7 episodes with Imaging
4 episodes with Imaging
5 episodes with Imaging
4 episodes with Imaging
7 episodes with Imaging
4 episodes with Imaging
3 episodes with Imaging
5 episodes with Imaging
6 episodes with Imaging
5 episodes with Imaging
5 episodes with Imaging
7 episodes with Imaging
5 episodes with Imaging
19 episodes with Imaging
19 episodes with Imaging
4 episodes with Imaging
3 episodes with Imaging
5 episodes with Imaging
5 episodes with Imaging
5 episodes with Imaging
5 episodes with Imaging
7 episodes with Imaging
7 episodes with Imaging
7 episodes with Imaging
10 episodes with Imaging
4 episodes with Imaging
12 episodes with Imaging
6 episodes with Imaging
10 episodes with Imaging
5 episodes with Imaging
9 episodes with Imaging
9 episodes with Imaging
5 episodes with Imaging
4 episodes with Imaging
3 episodes with Imaging
6 episodes with Imaging
11 episodes with Imaging
5 episodes with Imaging
17 episodes with Imaging
3 episodes with Imaging
4 episodes with Imaging
4 episodes with Imaging
3 episodes with Imaging
4 episodes with Imaging
6 episodes with Imaging
6 episodes with Imaging
6 episodes with Imaging
3 episodes with Imaging
8 episodes with Imaging
3 episodes with Imaging
6 episodes with Imaging
4 episodes with Imaging
5 episodes with Imaging
4 episodes with Imaging
3 episodes with Imaging
4 episodes with Imaging
4 episodes with Imaging
6 episodes with Imaging
3 episodes with Imaging
4 episodes with Imaging
14 episodes with Imaging
4 episodes with Imaging
3 episodes with Imaging
6 episodes with Imaging
4 episodes with Imaging
3 episodes with Imaging
8 episodes with Imaging
2 episodes with Imaging
69 episodes with Imaging
4 episodes with Imaging
4 episodes with Imaging
8 episodes with Imaging
6 episodes with Imaging
3 episodes with Imaging
4 episodes with Imaging
3 episodes with Imaging
2 episodes with Imaging
2 episodes with Imaging
2 episodes with Imaging
17 episodes with Imaging
4 episodes with Imaging
5 episodes with Imaging
3 episodes with Imaging
4 episodes with Imaging
3 episodes with Imaging
8 episodes with Imaging
4 episodes with Imaging
4 episodes with Imaging
7 episodes with Imaging
4 episodes with Imaging
10 episodes with Imaging
2 episodes with Imaging
5 episodes with Imaging
7 episodes with Imaging
4 episodes with Imaging
4 episodes with Imaging
3 episodes with Imaging
3 episodes with Imaging
How should prostate biopsy be performed in the MRI era, and what impact does biopsy strategy have on treatment planning?In this episode, Prof. Francesco Sanguedolce is joined by Prof. Francesco Giganti, Prof. Gianluca Giannarini and Prof. Lars Budäus to discuss the latest expert recommendations on prostate biopsy.The conversation explores the importance of high-quality MRI, targeted and perilesional biopsy strategies, the role of emerging imaging technologies and the ongoing debate surrounding systematic biopsy.The faculty also discuss how biopsy findings can influence decisions on focal therapy, nerve-sparing surgery and lymph node dissection, while highlighting current areas of consensus and the questions that still remain in clinical practice.ProBIOPSY: A Multidisciplinary International Consensus on Standards for Prostate Biopsy, European Urology, article in press. Doi.org/10.1016/j.eururo.2026.06.012)This podcast is brought to you in collaboration with the EAU Section of Urological Imaging.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
This webinar explores the evolving role of imaging in the diagnosis and management of gout. Our expert panel will discuss when and how to use ultrasound, dual-energy CT (DECT), crystal identification, and conventional radiography, while addressing practical questions such as the role of imaging in diagnostic uncertainty, serial disease monitoring, and whether ultrasound is changing the need for synovial fluid analysis in everyday practice. Panelists: Dr. Nicola Dalbeth Dr. John Fitzgerald Dr. Sarah Tedeschi Dr. Jack Cush (moderator)
Dr. Mahmud Mossa-Basha joins Dr. K to discuss contrast utilization and iodine stewardship in CT and MR imaging, highlighting lessons from the 2022 contrast shortage, strategies for optimizing contrast use, and the role of emerging technologies in supporting high-quality patient care. Claim your Credit Here This MR iCast episode is supported by Bracco Diagnostics Inc. through an unrestricted educational grant.
The Making Of Evelina Smiles - SIXDelays, Profit Sharing, and the Week Before Everything ChangesIn this episode Ashley sits down with Dr. Rich Constantine for a look at what the final stretch before a soft opening actually feels like. Setbacks, systems, 300 patients on a priority list, and the first peek at how Rich thinks about rewarding his team.What You'll Hear in This Episode:The Weeks Leading Up to Opening Supplies delayed by the Fourth of July holiday. Design Ergonomics trainer flew in but not everything was ready. Certificate of occupancy and zoning permit still pending over a landscaping detail. How Rich is keeping his head right when things do not go as planned. His mantra this week: pressure is a privilege.Where the Building Stands Software integrated. Imaging bridged with practice management. Phones hooked up. Wi-Fi working. TVs up. Chandeliers hung. Interior signage still coming. Half the waiting room furniture arrived. Scanner still in transit. Soft open pushed back.Training and Systems CareStack boot camps underway. Admin team working through UCR fees, third party financing conversations, patient portals, and building out Q and A for the AI phone system. Say this not that verbiage in place for both front desk and clinical team. Written playbooks and binders being built from scratch before the first patient walks in.300 Patients on the Priority List Rich casually drops one of the biggest wins of the episode. How the landing page, social media, QR code signage, and periodic email updates built a pipeline of 300 prospective patients before the doors even open. What he is doing first when the phones go live and why he is keeping ad spend light to start so he can see what is actually working.Merch, Giveaways, and Branded Everything The T-shirt rabbit hole. Why Rich wants to do premium branded gear or nothing at all. Printful, Real Thread, BYLT, and Cuts all come up. Ashley makes the case for buying great shirts and just getting them embroidered locally.Profit Sharing vs Bonus Culture Rich opens up about how he thinks about rewarding his team. Why he calls it profit sharing and not a bonus. Clear KPIs, collective rewards, and why nobody gets money that is not there. The difference between rewarding people blindly and building a team that understands the numbers. And why you do not own a business if you have to be there for it to run.Connect with Ashley: Instagram: @ashleyjovesddsConnect with Rich: Instagram @dr.c_smiles or richconstantinedds@gmail.comThank You to Our PartnersNet32: The dental marketplace that helps practice owners stop overpaying for supplies. Compare and save at net32.com/themakingof.Studio 8E8 — Dentistry's story-driven growth agency for startups. s8e8.com/vslKasper Opportunity Finder: Fill those empty chairs and reclaim lost revenue with one click. Get it free at meetkasper.com/register.Support the showFind Out MoreThank you for listening to The Making Of podcast. If you enjoyed it, please share with anyone you think will gain value from the show by clicking on one of the sharing tabs above.SUBSCRIBE to our NEWSLETTER HEREAlso, please consider leaving an honest review on iTunes. It helps other listeners find the show, and I would be forever grateful.Questions or comments? Feel free to contact us at - themakingofadental@gmail.comFollow us on Instagram or Facebook and improve your dental practice every day!Have you subscribed? Don't miss a single episode!
Endometriosis care is about so much more than surgery.In this episode, Nicole sits down with endometriosis excision surgeon Dr. Mallory Stuparich for a wide-ranging conversation on what it really takes to care for patients living with endometriosis.We discuss: The role of pelvic PT before and after surgery Setting realistic expectations for recovery Central sensitization and persistent pain Imaging, inflammation, and recurrence Why multidisciplinary care leads to better outcomes But one message stood above everything else:Our first job is to rebuild trust.Many patients with endometriosis have spent years feeling dismissed, misunderstood, or told their symptoms were normal. Before we can guide them toward healing, we have to help them feel seen, heard, and believed.Whether you're part of the surgical team or the rehabilitation team, that trust is where recovery begins. About Dr. Mallory StuparichDr. Mallory Stuparich is a fellowship-trained gynecologic surgeon specializing in advanced endometriosis excision surgery, adenomyosis, and complex pelvic pain. She is passionate about collaborative care and helping patients navigate every stage of their treatment journey with compassion, education, and evidence-based care.Downtraining MasterclassHelping patients with persistent pelvic pain requires more than great hands-on skills.Our Downtraining Masterclass provides practical frameworks for treating high-tension, pain-dominant patients with more confidence.
Johannes Galatsanos occupies an unusual dual perch in the quantum ecosystem. As a co-author of the inaugural MIT Quantum Index Report, he's helped map the entire quantum landscape at altitude; as co-founder and CEO of Diffraqtion, he's staked his career on one of its most under-discussed corners: quantum imaging. The company spun out of Saikat Guha's lab at the University of Maryland after more than a decade of DARPA-funded research, emerged from stealth in January 2026 with $4.2M in pre-seed funding, and is now racing toward on-sky telescope demonstrations and a 2028 satellite launch.This episode is for listeners who want a technically honest look at where the "quantum" label is doing real work in a sensor versus where it's shading into sophisticated photonics and analog computing. If you care about how quantum technologies actually reach the world — through markets, contracts, and hardware that ships — this conversation gives you a specific, concrete example to think with.What You'll LearnWhy a conventional camera can lose roughly 95% of the information a photon carries, and what quantum Fisher information theory says about recovering itHow Diffraqtion's device processes light directly in the photonic domain before converting it to electronic information — and why that matters for shot noiseThe honest answer to "is this really quantum?" — including where the technology sits between quantum information theory, photonics, and analog computingWhy a 6U CubeSat with a 10-centimeter aperture can plausibly compete with school-bus-sized observation satellites for specific tasksHow a "diffractive neural network" runs image classification at the speed of light with negligible power consumptionThe difference between Diffraqtion's hard-coded Gen 1 camera and the reprogrammable Gen 2 that can swap algorithms in orbit (canopy detection over the Amazon, ship detection over the Atlantic)Why the Habitable Worlds Observatory needs a coronagraph capability — and how you can build one by processing light rather than blocking itWhat quantum sensing needs from policy, capital, and PR to escape the shadow of quantum computingResources & LinksGuest & CompanyDiffraqtion — Company homepage; describes the technology, NASA/DARPA lineage, and the "quantum eye" framing referenced in the conversation.Johannes Galatsanos on LinkedIn — Recent activity including SmallSat Europe, the NASA Space to Soil Challenge, and GQIG Summit talks on quantum imaging.Papers & ReportsQuantum Index Report 2025 (arXiv) — The preprint of the MIT QIR, co-authored by Galatsanos. Essential reading for anyone trying to see the quantum landscape as a whole.MIT Sloan — New MIT Report Captures State of Quantum Computing — Background on the QIR and Galatsanos's research role at the MIT Initiative on the Digital Economy.MIT Sloan — Quantum Report Charts Growing Business Interest — Further QIR findings on the growth in corporate quantum mentions.Press & CoverageDiffraqtion Pre-Seed Announcement (PR Newswire) — Official release covering the $4.2M raise, DARPA contract, and founding team.Breaking Defense — DARPA Backs Diffraqtion — The most in-depth interview on the DARPA SBIR contract and programmable light plates.The Quantum Insider — Diffraqtion $4.2M Raise — Investor context including quotes from Chad Rigetti; technical claims on resolution and processing.Payload Space — Diffraqtion Emerges from Stealth — Commercial framing around the 6U CubeSat cost model.Defense One — Quantum Cameras Could Remake Space-Based Intelligence — Policy and defense framing.SponsorCisco Universal Quantum Switch — Outshift by Cisco — Cisco's incubation engine, building a scalable quantum network on open standards and vendor-agnostic architecture.Key Quotes & InsightsOn quantum information loss: "When you do a direct image… you lose something like 95% of information from that photon. So you leave 95% on the table, and the question was: how do you extract that back?"On what "quantum" really means here: Galatsanos is refreshingly candid — the device uses quantum Fisher information theory to set the physical limit and configure the hardware, but the runtime processing is closer to analog photonic computing than to gate-based quantum computing. He describes it as sitting between "quantum 1.0" and quantum sensing.On the frog's-eye analogy: Retinal ganglion cells can process shapes and trajectories faster than the brain — which is why you can catch a baseball or a falling fork before you consciously see it. Diffraqtion is trying to give satellites and robots the same kind of reflex.On the JPEG as a historical artifact: "JPEG was a little bit of a logical step… but now the thought is, forget about it — you don't even need that. The light itself already will tell you." The machine, unlike a human operator, doesn't need an image.On why quantum sensing lags in the discourse: Insight — quantum computing benefits from a single unifying narrative that every vendor can pull on. Quantum sensing has to invent its own story from scratch for each modality, which is a structural PR disadvantage more than a technical one.Related EpisodesEp. 65 — Quantum sensitivity breakthrough with Eli Levenson-Falk — On protocols that push measurements beyond conventional limits; a natural companion to the Fisher information discussion.Ep. 16 — Operating at the Quantum Limit with Dr. Dana Anderson — Infleqtion's CSO on quantum sensing alongside computing; useful context for why sensing is closer to deployment.Ep. 68 — Incubating quantum innovation with Vijoy Pandey of Outshift by Cisco — On quantum networks solving real problems today; a parallel to Diffraqtion's near-term deployment argument.Ep. 63 — A Programming Language for Quantum Simulations with Xiaodi Wu — Also from the University of...
Salvatore Brugaletta joins host Catherine Glass to explore how intracoronary imaging has transformed modern percutaneous coronary intervention (PCI). From intravascular ultrasound and optical CT to stent optimisation, vascular dysfunction, and AI-enhanced image interpretation, this episode examines the technologies improving procedural precision and patient outcomes. Timestamps: 0:55 – IVUS and OCT 2:58 – Endothelial recovery 4:55 – Stent failure mechanisms 6:19 – Barriers to adoption 8:18 – Innovations in imaging
Most geospatial data is gathered by satellites and cameras attached to planes, but a new decentralized network is helping amateur drone pilots capture and contribute ultra high resolution data. In this week's show, we go fly a drone and learn how that data is helping power next generation apps for things like disaster response.This episode originally ran in June 2025.We Meet: Alec Wilson, COO SpexiBill Lakeland, CEO Spexi Credits:This episode of SHIFT was produced by Jennifer Strong with help from Emma Cillekens. It was mixed by Garret Lang, with original music from him and Jacob Gorski. Art by Meg Marco.
Which imaging biomarkers matter most at diagnosis of GA, and how should they shape the decision to treat? In episode 1 of the GA in Practice miniseries on New Retina Radio, moderator Geeta Lalwani, MD, and panelists Murtaza Adam, MD, and Carl Danzig, MD, review the practical role of fundus autofluorescence and OCT in identifying high-risk GA, discuss ellipsoid zone integrity as an emerging endpoint, and work through a hypothetical case of an active, motivated patient with bilateral extrafoveal GA and good vision to explore how lifestyle, lesion characteristics, and patient education factor into early treatment decisions.
Dr. Sepideh Abdi reviews the key imaging features of premalignant bone and soft-tissue conditions, highlighting how radiologists can recognize early signs of malignant transformation in benign tumors and chronically injured tissues. From osteochondromas and enchondromas to neurofibromas, atypical lipomatous tumors, and radiation-induced sarcomas, this episode provides practical takeaways for identifying imaging findings that warrant closer evaluation and intervention. Imaging of Premalignant Conditions ofBone and Soft Tissue. Abdi et al. RadioGraphics 2025; 45(8):e240172.
You can spend years improving your business while unintentionally drifting away from the conviction that built it. Dr. Lona and Dr. Andrew Alekna explore why philosophy, continual learning, and investing in experiences that challenge and inspire you are essential to maintaining certainty in practice. Through stories from the Innate Summit, mission trips, and years of clinical experience, they discuss how reconnecting with your purpose strengthens your team, deepens patient trust, and brings renewed energy to the way you serve. When doctors continually invest in their own growth, they create practices that are more resilient, more aligned, and better equipped to change lives. Key Highlights 01:37 – Why the best seminars leave doctors wanting to bring that same energy back into their own practice. 04:17 – The surprising difference experience makes in developing certainty without feeling the need to convince patients. 06:02 – What years in practice reveal about patient decisions that newer doctors often take personally. 08:02 – Why strengthening your conviction before returning to practice changes how you serve every patient. 09:32 – The unexpected connection between personal growth, professional energy, and the patients who begin showing up in your office. 12:22 – How bringing team members to live events can reshape practice culture long after the seminar ends. 15:22 – A story from India that reveals where true certainty is often built. 20:02 – Why some of the greatest lessons from serving others end up transforming the doctor more than the patient. 23:02 – How maintaining curiosity keeps both clinical care and long-term patient relationships from becoming routine. 25:12 – The simple mindset shift that helps practices sustain purpose, enthusiasm, and growth long after the seminar ends. 26:59 - Imaging technology is evolving rapidly, and chiropractors have more opportunities than ever to improve efficiency and patient care. Dr. Pete sits down with J.R. Marsee from Success Partner Blue Ridge Imaging to explore turnkey imaging solutions, ongoing support, and the growing role of AI in modern chiropractic practices. Together, they discuss how the right technology partner can help practices operate with greater confidence today while preparing for the future. Resources Mentioned For more information about Blue Ridge please visit: https://blueridgeimagingtechnologies.com To schedule a Strategy Session with Dr Lona: https://go.oncehub.com/DrLonaBuildPodcast To schedule a Strategy Session with Dr Bobby: https://go.oncehub.com/DrBobbyBuildPodcast Learn more about the Remarkable CEO Podcast: https://theremarkablepractice.com/podcast
What if one of the earliest clues to Alzheimer's disease could be found during a routine eye exam? In this episode of Tomorrow's Cure, host Lindsey Seavert sits down with Dr. Oana Dumitrascu, a neurologist at Mayo Clinic, and Dr. Yalin Wang, a researcher at Arizona State University, to explore how retinal imaging and artificial intelligence may help identify signs of Alzheimer's disease years before symptoms appear. Together, they discuss the science behind “seeing the brain through the eye,” how AI can detect patterns invisible to the human eye, and why earlier detection could transform research, prevention, and patient care. This conversation highlights an exciting intersection of neuroscience, artificial intelligence, and preventive medicine. How to listen and stay connected: Subscribe to Tomorrow's Cure on your favorite podcast app and follow the show so you never miss an episode. Get the latest health information from Mayo Clinic's experts—subscribe to Mayo Clinic's newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic: Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/ Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
Recovering from low back pain isn't just about finding the right exercise. It's about understanding your body, building confidence, and avoiding the common mistakes that can keep you stuck. In this episode, Conor is joined by doctor of physical therapy Dr. Julian Burd to discuss why most cases of low back pain are non-specific, when imaging is actually useful, and how beliefs about pain can influence recovery. They explore the role of movement, graded exposure, and why both doing too much and doing too little can slow progress. Julian also shares practical frameworks he uses with clients to help them understand pain, monitor progress, and return to training without fear. The conversation covers common misconceptions around MRI findings, disc injuries, strength training, and why consistency with the fundamentals often matters more than chasing complicated rehabilitation techniques. If you're dealing with recurring back pain, this episode will give you practical strategies to approach recovery with greater clarity and confidence. Find Julian on IG: @jayburdpt Julian's Website: https://www.jayburdpt.com Conor's IG: @conorosheafit
Discover the four critical benchmarks top imaging centers track for remote contrast coverage—response time, reaction management, documentation, and cancellation rates—and why CMS's permanent 2026 virtual supervision rules demand better measurement. Learn more at https://www.contrast-connect.com/blog-post/remote-contrast-coverage-performance-benchmarks-for-imaging-networks ContrastConnect City: Las Vegas Address: Las vegas Website: https://www.contrast-connect.com/
Imaging is central to osteosarcoma and Ewing sarcoma diagnosis and treatment, yet no international consensus defines optimal modalities or schedules to date. Hans presents harmonised European recommendations for the imaging of bone sarcomas, fulfilling the requirement for a methodical, systematic, and uniform approach to the diagnosis, treatment response assessment and post-therapy surveillance of osteosarcoma and Ewing sarcoma. Click here to read the full article: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(26)00141-5/fulltext
Stugotz, Izzy, Taylor and Mikey A play three games including: "Who won the trade?", "Think about it Thursday", and "Taylor fixes American sports with something from soccer". Plus, Izzy redrafts the 2018 NBA draft.See omnystudio.com/listener for privacy information.
Host: Emer Joyce Guest: Lorenz Raeber Want to watch that extended interview on https://esc365.escardio.org/event/2558?resource=interview Go to: Want to watch that episode? Go to: https://esc365.escardio.org/event/2558 Disclaimer ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own. Declarations of interests Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Lorenz Raeber has declared to have potential conflicts of interest to report: consultation/speaker fees from Abbott, Boston Scientific, Occlutech, and research grants to the institution by Abbott, Heartflow, Novo Nordisk and Heartflow. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
This episode covers: Cardiology This Week: A concise summary of recent studies Host: Emer Joyce Guests: Yasmina Bououdina, JP Carpenter, Milton Packer, Lorenz Raeber Want to watch that episode? Go to: https://esc365.escardio.org/event/2558 Want to watch that extended interview on PCI guidance by intracoronary imaging, go to: https://esc365.escardio.org/event/2558?resource=interview Disclaimer ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own. Declarations of interests Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Milton Packer has declared to have potential conflicts of interest to report: 89bio, Abbvie, Actavis, Altimmune, Alnylam, Amarin, Amgen, Ardelyx, ARMGO, AstraZeneca, Attralus, Biopeutics, Boehringer Ingelheim, Caladrius, Casana, CSL Behring, Cytokinetics, Daiichi Sankyo, Imara, Lilly, Medtronic, Moderna, Novartis, NovoNordisk, Pharmacocosmos, Regeneron, Roche, Salamandra. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Lorenz Raeber has declared to have potential conflicts of interest to report: consultation/speaker fees from Abbott, Boston Scientific, Occlutech, and research grants to the institution by Abbott, Heartflow, Novo Nordisk and Heartflow. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
In this episode of The Radiology Report Podcast, Daniel Arnold sits down with Ohad Arazi, incoming CEO of Subtle Medical, to discuss the future of AI in medical imaging, the challenges facing radiology workflows, and the leadership lessons he's learned from more than 20 years in healthcare technology. From the early days of PACS to today's AI-driven imaging ecosystem, Ohad shares why some of the biggest opportunities in radiology may exist before an image ever reaches the radiologist. The conversation explores MRI acceleration, workflow optimization, imaging operations, startup leadership, and how healthcare organizations can unlock greater efficiency, image quality, and patient outcomes through innovation. Whether you're a radiologist, imaging leader, healthcare executive, or technology innovator, this episode offers a unique perspective on where radiology is headed next.
Georg Northoff is Canada Research Chair in Mind, Brain, Imaging, and Neuroethics at the University of Ottawa's Institute of Mental Health Research, a practising psychiatrist, neuroscientist, and philosopher, and one of the founders of neurophilosophy. Over two decades his work has reframed the brain's resting spontaneous activity — the Default Mode Network — as the primary architect of consciousness and selfhood.He is the author of The Spontaneous Brain, alongside more accessible introductions including NeuroWaves: Brain, Time, and Consciousness (2023) and NeuroPsychoAnalysis (2023).________________In this conversation, I sit down with Georg to explore his spatial-temporal neuroscience — a framework that replaces the mind-body problem with the world-brain relationship. We begin with AI consciousness, move into the Default Mode Network and why depression is a brain running too slowly, his non-dual awareness study with meditators, his critique of Heidegger as still anthropocentric, and Whitehead's process ontology. A conversation that starts with ChatGPT and ends near the edge of what it means to exist.________________
Equipping Hour | Imaging God in a Broken World | War and Criminal Justice by OrlandoGrace
Join our online community: https://www.skool.com/nailed-it-ortho/about Dr. Gianakos Instagram: https://www.instagram.com/dr.ariannagianakos/?hl=en In this episode, Dr. Ariana Gianakos joins us to talk about sports foot and ankle injuries. We cover common athletic injuries, evaluation strategies, treatment options, rehab, and the challenges of getting athletes safely back to play. Dr. Gianakos shares her journey into sports foot and ankle surgery, how her own athletic injuries shaped her career, and the international fellowship experiences that helped define her approach to treating elite athletes. We also discuss: Common sports-related foot and ankle injuries Key anatomy and physical exam pearls Imaging strategies and when to order MRIs Conservative vs surgical treatment options Return-to-play timelines for athletes Managing instability, tendon injuries, and high ankle sprains The role of PRP, biologics, and peptides in sports medicine Building global consensus in foot and ankle sports care Enjoy! Arianna Gianakos, DO, is an orthopaedic surgeon who specializes in sports-related injuries of the foot and ankle, including Achilles tendon injuries; ankle sprains and instability; ligament reconstruction; and trauma-related foot and ankle fractures, as well as various other foot and ankle conditions. Dr. Gianakos' interest in sports medicine—particularly foot and ankle sports medicine—is the result of a long, personal history with sports. She was an All-American Athlete, former collegiate basketball player, and track and field athlete who had her own share of injuries and orthopaedic surgeries. "My experience taught me the importance of having a physician who was passionate about getting patients back on their feet so they are able to return to sports," she says. "I chose a career where I could help patients in the same way my orthopaedic surgeons helped me." Her approaches include cutting-edge, minimally invasive surgeries, including in-office needle arthroscopy, and a variety of nonsurgical interventions, such as platelet-rich plasma (PRP) therapy, stem cell therapy, and fat cell therapy. In addition to her clinical work, Dr. Gianakos is an assistant professor of Orthopaedics & Rehabilitation at Yale School of Medicine. She has collaborated on studies of cartilage regeneration, tendon healing, and bone growth, and has a personal research focus on gender- and sex-related differences in foot and ankle injuries and outcomes. Dr. Ariana Gianakos earned her Bachelor of Science degree from McGill University before completing her Doctor of Osteopathic Medicine degree at Lake Erie College of Osteopathic Medicine. She went on to complete her orthopedic surgery residency at Rutgers Health, followed by a fellowship in Orthopedic Foot and Ankle Surgery at Massachusetts General Hospital through Harvard Medical School. She also completed advanced international training in foot and ankle IONA and sports medicine through NYU Langone Health. In addition, she is a PhD candidate at the University of Amsterdam, where her research focuses on gender and sex-related differences in foot and ankle surgery.
Sermon for Sunday, June 21, 2026 - 4th Sunday at Pentecost, 1`2th Sunday of Ordinary Time.
Your eyes reveal what you cannot see. Advanced OCT and OCT Angiography technology now allows eye care professionals to detect and prevent diseases that would otherwise lead to blindness and to diagnose systemic conditions like diabetes, hypertension, and cardiovascular disease before symptoms appear. In this episode, Dr. Kerry Gelb sits down with Dr. Carolyn Majcher, a leading expert in retinal imaging and vitreoretinal disease, to explore how this breakthrough technology is transforming preventive medicine. ❤️ WHY THIS MATTERS: Early detection saves vision. Early detection saves lives. Eye imaging now detects: ✓ Diabetes (before the patient knows) ✓ Hypertension (silently damaging organs) ✓ Cardiovascular disease (showing warning signs in the retina) ✓ Retinal diseases (before blindness occurs) ✓ Systemic conditions (through the eye as a biomarker) Connect with Dr. Carolyn Majcher: https://www.instagram.com/retina_queen/
What if a single scan could detect blindness, diabetes, and heart disease before you feel any symptoms? In Part 2 of our conversation with Dr. Carolyn Majcher, one of the leading retinal specialists in the country, we go deeper into the world of advanced OCT imaging and OCT Angiography, the technology that is quietly revolutionizing eye care and saving lives. Your eyes are not just for seeing they are a window into your entire body. This episode will change the way you think about your health.
https://www.contrast-connect.com/blog-post/remote-contrast-coverage-staffing-plan-daytime-after-hours-and-holiday-coverage-modelsCMS permanently authorized virtual direct supervision for contrast imaging in 2026. Learn how imaging operations can staff remote supervision, optimize capacity, ensure compliance, and slash costs without full-time radiologist hires. ContrastConnect City: Las Vegas Address: Las vegas Website: https://www.contrast-connect.com/
Dr. Yashbir Singh sits speaks with Dr. Imon Banerjee to explore how multimodal data and fair AI techniques are reshaping cancer imaging and clinical decision making. The conversation dives into bridging computer science and medicine, tackling bias in healthcare AI, and what it takes to translate innovation into real patient impact. Radiology: Imaging Cancer
Children need to feel seen, safe, and supported! Laura Gould BS CCLS joins host, Raisa Amiruddin MBBS, to discuss the value of soft language, gentle validation, and the impact of giving children a voice in their own care. Discover how simple human connection can transform imaging suites into warm, safe spaces for kids.
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode, Peter explores the critical topic of breast cancer screening, examining why thousands of women continue to die from breast cancer each year despite the availability of effective screening tools. He explains the strengths and limitations of current screening strategies, reviews the recommendations from major medical organizations, and discusses why screening guidance can often seem confusing or contradictory. Peter outlines a practical framework for understanding breast cancer risk and personalizing screening decisions, including when to begin screening, how frequently to screen, and which imaging modalities may be most appropriate based on an individual's risk profile. Throughout the episode, he emphasizes that while population-based guidelines provide an important foundation, optimizing outcomes requires a more personalized approach aimed at helping women make informed screening decisions that can improve the chances of early detection and successful treatment. We discuss: Why women still die from breast cancer: the benefits of screening, the problem of under-screening, and the need for risk-based screening strategies [1:45]; Current screening recommendations, why they differ between organizations, and the importance of personalized screening decisions [6:30]; A framework for personalizing screening [8:45]; Assessing baseline breast cancer risk: genetics, family history, breast density, lifestyle factors, and the role of risk calculators in personalized screening [9:30]; Balancing cancer detection and false positives: how breast cancer risk influences screening intensity and imaging choices [17:45]; Mammography as the foundation of breast cancer screening: detecting ductal carcinoma in situ (DCIS) and the advantages of 3D versus 2D mammography [21:00]; MRI for high-risk women: the benefits of supplemental screening, abbreviated MRI, and the emerging role of contrast-enhanced mammography [23:00]; The role of ultrasound: supplemental cancer detection, diagnostic evaluation, and limitations compared with mammography and MRI [26:00]; Choosing the right breast cancer screening strategy: imaging modality selection, screening hierarchies, and the importance of imaging center quality [28:00]; How often should you screen for breast cancer? [30:15]; At what age should you start screening? [37:30]; Breast cancer in younger women: aggressive tumor biology, BRCA-related risk, breast density, and individualized decisions about when to begin screening [41:45]; Inflammatory breast cancer, the limitations of screening mammography for symptomatic disease, and the importance of promptly evaluating new breast symptoms in both women and men [44:45]; From risk assessment to personalized screening: a practical framework for reducing breast cancer mortality through earlier and more effective detection [46:30]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube
Peter Barrett of Halliburton discusses the evolution and technical importance of borehole imaging within the energy industry. He explains how this technology uses acoustic and resistivity data to create 360-degree subsurface visualizations, enabling experts to identify geological fractures and bedding. Barrett highlights the critical role of the SPWLA, a professional society that fosters global collaboration and the development of new digital initiatives. The conversation covers significant historical milestones, such as the 1969 origins of the first acoustic images and the later breakthrough of oil-based mud imaging. Ultimately, Barrett emphasizes the shift toward integrated data analysis and the vital importance of mentoring the next generation of petrophysicists.
Join United Imaging, an SNMMI Value Initiative member, for an insightful discussion with moderator Lance Burrell and speakers Jennifer Robinson, Amanda Dieselkamp, and Will Cofer on the evolving role of mobile PET CT in expanding access to advanced molecular imaging. This podcast is brought to you by United Imaging, an SNMMI Value Initiative member. Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X
Equipping Hour | Imaging God in a Broken World | Sex & Gender (2) by OrlandoGrace
Equipping Hour | Imaging God in a Broken World | End of Life by OrlandoGrace
The Real Truth About Health Free 17 Day Live Online Conference Podcast
From IV therapies to PET scans and detox strategies, Dr. Josh shares what works in clinical settings to reverse dementia symptoms. #DementiaReversal #BrainDetox #NeuroImaging #FunctionalMedicine
A Chiropractor's Road to Ghana: Dr. Craig Slapinski on Travel, Spinal Decompression, and Finding Your Path Episode Sponsor This episode of Conversations with a Chiropractor is supported by Lemongrove Oil. Visit Lemongrove Oil and use coupon code DRSTEPHANIE at checkout to save 10% on your next order. This offer is exclusive to Conversations with a Chiropractor listeners. Lemongrove Oil: https://www.lemongroveoil.com/ Episode Description In this episode of Conversations with a Chiropractor, Dr. Stephanie Wautier sits down with Dr. Craig Slapinski, a chiropractor and former Palmer College classmate whose career has taken him from the Midwest to Ghana, Nigeria, and beyond. Dr. Craig shares how a love of travel shaped his life long before chiropractic school. From building houses in Mexico as a teenager to studying abroad in London, backpacking through Europe, exploring China, and traveling through Southeast Asia, his path has always included curiosity, adventure, and a willingness to step into unfamiliar places. That same spirit eventually led him to Ghana after chiropractic school, where he worked in a high-volume clinic and quickly learned how to trust his hands, sharpen his adjusting skills, and serve patients with limited equipment and a lot of real-world pressure. Years later, he returned to West Africa with a more focused mission: to bring nonsurgical spinal decompression care to communities where access to this type of treatment was limited. Stephanie and Dr. Craig talk about chiropractic in Ghana and Nigeria, what makes the healthcare experience different from the United States, and how his clinics use spinal decompression, cold laser, exercise, ergonomics, and rehabilitation to help patients dealing with disc-related back pain. This conversation is also about finding your own path. Dr. Craig's story is a reminder that a chiropractic career can take many shapes, and that sometimes the road you end up on is not the one you planned, but the one that fits who you are becoming. This episode is meant to inform and inspire, not replace personal medical advice. If you are dealing with back pain, disc issues, sciatica, or considering surgery, please work with a qualified healthcare professional who can evaluate your individual situation. In This Episode, Discover How Dr. Craig Slapinski and Dr. Stephanie Wautier met at Palmer College of Chiropractic Dr. Craig's early love of international travel What he learned from traveling through Mexico, Europe, China, Thailand, Laos, and Cambodia How a planned move to China turned into an unexpected opportunity in Ghana What it was like practicing chiropractic in Ghana right out of school How high-volume care helped Dr. Craig sharpen his adjusting skills How he became interested in nonsurgical spinal decompression What spinal decompression is designed to do for disc-related back pain Why some patients may explore decompression before considering surgery How Dr. Craig combines decompression, cold laser, exercise, and ergonomics Why he returned to Ghana and eventually expanded into Nigeria The differences between insurance-driven care in the United States and cash-based care in Africa What healthcare access, MRIs, and patient education can look like in Ghana and Nigeria How Dr. Craig's clinics serve patients across West Africa Why chiropractic careers can take many different paths Stay Connected & Explore Learn More About Dr. Craig Slapinski: To learn more about Dr. Craig's work in West Africa, search: Spine and Nerve Center Ghana Spine and Nerve Center Nigeria Episode Sponsor: Lemongrove Oil: https://www.lemongroveoil.com/ Use coupon code DRSTEPHANIE at checkout for 10% off. Connect with Conversations with a Chiropractor: Follow Us on YouTube: http://www.youtube.com/@ConversationswithaChiro Follow Dr. Stephanie on Facebook: https://www.facebook.com/wautierwellness Email for show-related inquiries and sponsorships: drstephaniewautier@yahoo.com Want to be a guest on Conversations with a Chiropractor? Send Stephanie Wautier a message on PodMatch, here: https://www.podmatch.com/hostdetailpreview/drstephanie Credits Podcast production by Brand|Sound. Start your podcast journey by emailing brandsoundpodcasts@gmail.com. Chapters 00:00 Introduction to Conversations with a Chiropractor 01:00 Meet Dr. Craig Slapinski 01:19 A Love of Travel Begins 02:41 Backpacking Through Southeast Asia 03:31 Navigating Different Cultures and Languages 04:35 From a China Plan to a Ghana Opportunity 05:07 Practicing Chiropractic in Ghana 06:31 Building Confidence as a Chiropractor 07:11 Returning to the US and Discovering Decompression 08:00 Lemongrove Oil Sponsor Message 09:52 What Nonsurgical Spinal Decompression Does 11:10 Disc Pain, Surgery, and Other Options 12:08 Bringing Decompression Back to Ghana 13:03 Opening Clinics in Ghana and Nigeria 15:05 Building a Team Across West Africa 15:47 Chiropractic Training and Practice in Africa 16:40 Chiropractic, Insurance, and Patient Choice 18:17 Caring for a Wide Range of Patients 19:00 Food and Culture in Ghana 20:16 Educating Patients Across Languages 21:15 Staffing and Patient Care in the Clinics 22:00 MRIs, Cost, and Access to Imaging 23:09 What Treatment Looks Like 25:00 Is Decompression Comfortable? 25:54 Results With Decompression Care 26:40 How to Find Dr. Craig Slapinski 27:23 Finding Your Path in Chiropractic 28:00 Closing Thoughts 28:37 Lemongrove Oil Sponsor Message
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/the-evolving-role-of-antibody-drug-conjugates-in-metastatic-triple-negative-breast-cancer-10800SummaryThis CME/CE-certified podcast will provide multidisciplinary clinicians with an evidence-based update on the evolving role of TROP2-directed antibody-drug conjugates (ADCs) in the frontline treatment of metastatic triple-negative breast cancer. A medical and an ocular oncology specialist review the latest efficacy and safety data from pivotal clinical trials evaluating ADCs, their integration into contemporary treatment algorithms, and guideline recommendations based on PD-L1 status, BRCA mutation status, and immunotherapy eligibility. Learners will explore key factors influencing treatment selection, compare the benefits and limitations of more established therapeutic options, and examine practical strategies for preventing, recognizing, and managing ADC-associated toxicities. Special emphasis will be placed on multidisciplinary approaches to the management of ocular adverse events and other clinically significant toxicities to optimize patient outcomes and support safe implementation of these therapies in clinical practice.Learning ObjectivesEvaluate the current and emerging clinical evidence surrounding the use of trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugates (ADCs) in the first-line treatment of metastatic triple-negative breast cancer (TNBC)Integrate TROP2-directed ADCs into frontline treatment regimens for metastatic TNBC based on the latest clinical evidence, guidelines, and patient- and tumor-specific factorsApply multidisciplinary and patient-centric strategies for the prevention, recognition, and management of toxicities associated with the use of TROP2-directed ADCs in patients with metastatic TNBCThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.50 contact hours (which includes 0.50 hours of pharmacology). For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Faculty and Moderator Aditya Bardia, MDProgram Director, Breast Medical Oncology, UCLAProfessor of Medicine, UCLALos Angeles, CADr. Bardia has disclosed the following financial relationships:Consultant: Alyssum, AstraZeneca/Daiichi, BMS, Eli Lilly, Genentech, Gilead, Menarini, Merck, Novartis, Pfizer, VyomeAdvisor/Advisory Board: Alyssum, AstraZeneca/Daiichi, Eli Lilly, Genentech, Gilead, Menarini, Merck, Novartis, Pfizer, VyomeContracted Research: AstraZeneca/Daiichi, Eli Lilly, Genentech, Gilead, Menarini, Merck, Novartis, PfizerStock options: Vyome (immuno-inflammatory and rare diseases)All of his consultant, advisor/advisory board, and contracted research disclosures are related to cancer.Maura Di Nicola, MDAssistant Professor of OphthalmologyBascom Palmer Eye InstituteMedical Director of Imaging and EchographyBascom Palmer Eye InstituteMiami, FLDr. Di Nicola has disclosed the following financial relationships:Consultant: AbbVie (ophthalmology), SpringWorks Therapeutics (oncology)Advisor/Advisory Board: AbbVie (ophthalmology)Research Grant: Castle Biosciences (ocular oncology)Please review additional planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by a medical education grant from AstraZeneca Pharmaceuticals and a medical education grant from Daiichi Sankyo, Inc.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
How do you feel about mammograms? Have you had one? More than one? Or, are you feeling guilty or reckless for not getting one yet? Conventional medical dogma is definitely to get regular mammograms. Mammograms are our first line of defense against breast cancer. You probably personally know someone who has encouraged you to get a mammogram because a mammogram discovered cancer in them or someone they love, and they want to make sure you're taking care of your health by getting screened before it's too late. We're very indoctrinated that mammograms save lives. Too bad they don't.https://auria.care/science coupon code: drjenn20U.S. QT imaging locations: https://www.qtimaging.com/locations/ Dr Jenn Simmons' Podcast episodes:11, 34, 64, 96, 125, 142, 144Cochrane report on mammographic screeningBoobs: The War on Breasts Documentary by Megan SmithArticle in the Journal of the Royal Society of Medicine to an article called “Mammography Screening is Harmful and Should be Abandoned.”Are you ready to give your cells their best chance to not have to stop living before they die by allowing them access to physiologic levels of hormones, but aren't sure how to even get started? Join the waitlist for my new beta program here and help me figure out how best to help wonderful women like you get the hormone care they deserve!Join the Waitlist HereCome visit me: www.healthcouragecollective.comemail me: healthcouragecollective@gmail.com
AI in Imaging: How Will it Change What We Do Guest: Tim Poterucha, M.D. Host: Kyle Klarich, M.D. Artificial intelligence (AI) is beginning to reshape how we acquire, interpret, and act on cardiovascular imaging, particularly echocardiography. In this episode, we'll walk through how we got here—from the historical innovation arc of echo to modern AI tools that segment images, detect disease, and support interpretation—and discuss what is real, what is hype, and where the true clinical opportunities and risks lie. We'll also explore what this means for practicing clinicians and trainees who are considering a future in imaging. Topics Discussed: When it comes specifically to cardiovascular imaging, what is the current role of AI, and why is imaging such a natural fit for these tools? What are the problems with how we interpret imaging now, and what are the risks of AI? What is hype right now, and what is real? Is AI going to replace cardiologists for medical imaging interpretation, and should cardiology fellows be worried about going into imaging with the rise of AI? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here. Recorded 01-December-2025
A 25-year-old pregnant woman presents with a 1-day history of progressive pain and swelling. The foot is cold, pulseless and neurologic function is deteriorating by the hour. Imaging shows a massive iliofemoral DVT. Now both the limb and the pregnancy are threatened. Do you anticoagulate, thrombolyse or operate? Join us as we break down the management and decision making behind this rare but devastating case.Hosts:· Christian Hadeed -PGY 4 General Surgery, Brookdale Hospital Medical Center· Paul Haser -Division Chief, Vascular Surgery, Brookdale Hospital Medical Center· Andrew Harrington, Vascular surgery, Brookdale Hospital Medical Center· Lucio Flores, Vascular surgery, Brookdale Hospital Medical CenterLearning objectives:- Recognize the clinical presentation and pathophysiology of phlegmasia cerulea dolens- Describe how pregnancy affects decision making in patients with phlegmasia and venous thromboembolic disease- Discuss the goals of treatment for patients with DVT's and identify when operative intervention is indicated- Describe the sequelae of DVT's and how this relates to post thrombotic syndrome- Review the indications, risks, and limitations of anticoagulation, catheter-directed thrombolysis, thrombectomy, and fasciotomy in the management of DVT and phlegmasia.- Explain the role of IVUS in managing venous thromboembolic disease and May Thurner syndromeReferences:- Vedantham, S., Goldhaber, S. Z., Julian, J. A., Kahn, S. R., Jaff, M. R., Cohen, D. J., Magnuson, E., Razavi, M. K., Comerota, A. J., Gornik, H. L., Murphy, T. P., Lewis, L., Duncan, J. R., Nieters, P., Derfler, M. C., Filion, M., Gu, C.-S., Kee, S., Schneider, J., … Kearon, C. (2017). Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. New England Journal of Medicine, 377(23), 2240–2252. https://doi.org/10.1056/NEJMoa1615066- Gomes, M. S., Guimarães, M., & Montenegro, N. (2019). Thrombolysis in pregnancy: A literature review. Journal of Maternal-Fetal & Neonatal Medicine, 32(14), 2418–2428. https://doi.org/10.1080/14767058.2018.1438402- Mangla, A., & Hamad, H. (2023). May-Thurner syndrome. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554377/- Bates, S. M., Rajasekhar, A., Middeldorp, S., McLintock, C., Rodger, M. A., James, A. H., et al. (2018). American Society of Hematology 2018 guidelines for management of venous thromboembolism: Venous thromboembolism in the context of pregnancy. Blood Advances, 2(22), 3317–3359. https://doi.org/10.1182/bloodadvances.2018024802- Kahn, S. R., Comerota, A. J., Cushman, M., Evans, N. S., Ginsberg, J. S., Goldenberg, N. A., et al. (2014). The postthrombotic syndrome: Evidence-based prevention, diagnosis, and treatment strategies. Circulation, 130(18), 1636–1661. https://doi.org/10.1161/CIR.0000000000000130 https://pubmed.ncbi.nlm.nih.gov/25246013/Sponsor URL: https://www.goremedical.com/If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US
Imaging in Subclinical Psoriatic Arthritis CAR-T For Rheumatoid Arthritis This Is a Woman's World: Women's Health in Rheumatic Disease Dietary Interventions in PsA
Dr. Julie Chen, Chief Medical Officer at Radence, outlines the use of genomic precision medicine and advanced biomarkers and imaging technology for early detection and diagnosis of disease, with a focus on extending the health span, not just the lifespan, of their clients. This comprehensive membership-based model aggregates members' health data to create a 360° view of their health risks. AI is a critical tool for identifying trends in longitudinal data, enabling more accurate and personalized health monitoring for both those who are healthy and those recovering from an existing condition. Julie explains, "Our model is a membership-based model primarily because a lot of the leading-edge technology is not insurance-covered. And so we're able to then utilize what is necessary for the diagnosis and the management, and actionable steps for the members, without having to worry about what insurance will or will not cover." "Our members come through, and we actually aggregate all of their outside medical records and data because we want to see what their baseline health has been up to the point that they join us as a member. And then at that point, we actually get from the cellular level all the way up to the organ level and functionality level, we start to aggregate information about their genomics, so the blueprint of who they are health-wise." "The key focus here is really looking at the concept that longevity is a larger picture phrase that has been in this industry, used across the board for a lot of different things. That could encompass biohacking, to true evidence-based genomic precision medicine, to just trends of what people are using. So I think it's really important for your listeners to understand that longevity is theoretically in the category of what we're doing in that space, but the very important point is to really look at the space, as there are a lot of things on the market now." #Radence #GenomicMedicine #PrecisionMedicine #EarlyDetection #HealthSpan #Longevity #AIinHealthcare #PreventiveCare Radence.com Download the transcript here
Dr. Julie Chen, Chief Medical Officer at Radence, outlines the use of genomic precision medicine and advanced biomarkers and imaging technology for early detection and diagnosis of disease, with a focus on extending the health span, not just the lifespan, of their clients. This comprehensive membership-based model aggregates members' health data to create a 360° view of their health risks. AI is a critical tool for identifying trends in longitudinal data, enabling more accurate and personalized health monitoring for both those who are healthy and those recovering from an existing condition. Julie explains, "Our model is a membership-based model primarily because a lot of the leading-edge technology is not insurance-covered. And so we're able to then utilize what is necessary for the diagnosis and the management, and actionable steps for the members, without having to worry about what insurance will or will not cover." "Our members come through, and we actually aggregate all of their outside medical records and data because we want to see what their baseline health has been up to the point that they join us as a member. And then at that point, we actually get from the cellular level all the way up to the organ level and functionality level, we start to aggregate information about their genomics, so the blueprint of who they are health-wise." "The key focus here is really looking at the concept that longevity is a larger picture phrase that has been in this industry, used across the board for a lot of different things. That could encompass biohacking, to true evidence-based genomic precision medicine, to just trends of what people are using. So I think it's really important for your listeners to understand that longevity is theoretically in the category of what we're doing in that space, but the very important point is to really look at the space, as there are a lot of things on the market now." #Radence #GenomicMedicine #PrecisionMedicine #EarlyDetection #HealthSpan #Longevity #AIinHealthcare #PreventiveCare Radence.com Listen to the podcast here
May 31, 2026 / Sunday Sermon: Imaging the Trinity / Fr. Ryan Jordan by Trinity Episcopal Church Vero Beach
Full article: Human-in-the-Loop Large Language Model–Augmented Diagnostic Reasoning in Thoracic Imaging: Impact of Radiologic Expertise Use of LLMs in the diagnostic reasoning process can either improve or hinder performance. Pranjal Rai, MD, discusses the AJR article by Song et al. exploring the association of reader expertise and reader performance when using LLMs as a diagnostic aid.
Equipping Hour | Imaging God in a Broken World | Sex and Gender (1) by OrlandoGrace
This week we review a recent report from the team at Amrita Institute in Cocchin, India about their use of extended reality and virtual reality as well as heart model printing to aid in planning for complex intracardiac baffles for the treatment of complex congenital heart defects. What was the process used to provide actionable advice in the operating room during surgery? How has the team in southern India created a workflow that can accurately predict this complex anatomy and the patches needed to successfully septate complex hearts? We speak with the director of the 3D imaging group at Amrita, Professor Mahesh Kappanayil about this remarkable achievement of imaging in collaboration with surgery. DOI: 10.1016/j.jtcvs.2026.03.616
Preview for Later Today: Doug Messier describes NASA's innovative mission using robotic hoppers to survey the lunar South Pole, seeking water and potential sites for a future moon base through high-resolution imaging in the moon's environment.MAY 1952
Our U.S. Healthcare Analyst Erin Wright discusses how health tracking and preventive diagnostics could influence healthcare costs and different industries, from fitness to retail.Read more insights from Morgan Stanley.----- Transcript -----Welcome to Thoughts on the Market. I'm Erin Wright, Morgan Stanley's U.S. Healthcare Services Analyst. Today – the emergence of the self-directed patient and its implications. It's Tuesday, May 12th at 10am in New York. A blood test ordered from your phone. A wearable that tracks your sleep or nudges you to move, recover, hydrate, or rethink last night's dinner. Preventive health is moving out of the clinic and into everyday life. And that shift is becoming an investable theme. In essence, healthcare is moving from reactive to proactive. Instead of waiting for symptoms, more consumers are using lab tests, wearables, imaging, and digital tools to spot some these risks earlier. And this shift reaches well beyond healthcare. On our estimates, the U.S. spends about [$]3.4 trillion annually on chronic diseases, including lost economic productivity. About [$]1.4 trillion of 2024 spend was tied to preventable disease. So the big investment question is: can earlier detection and behavior change bend the cost curve? We think expanded preventive testing, screening, and monitoring can help avoid roughly [$]200 billion to [$]800 billion of U.S. healthcare spend by 2050. That assumes preventive testing reduces preventable disease costs by about 10% to 30% based on our analysis. Direct-to-consumer lab testing lets people order lab tests directly, often online, without starting with a traditional doctor visit. We see this as a roughly $4 billion U.S. market, which has more than doubled since 2021. And it's no longer niche. Our AlphaWise survey found that about 34% of respondents completed a voluntary wellness lab test in the past three years. Among users, the average was 3.2 tests, suggesting this is not just a one-time behavior. The most common test was a general health profile, used by about 45 percent of recent testers. Wearables are the other part of the story. Our survey found that 41 percent of respondents currently use a wearable or fitness device, while another 22 percent are interested in getting one. More importantly, people are acting on the data. 34 percent of wearable users today regularly change behaviors or decisions based on their device, and 52 percent even sometimes do so, based on our survey. That creates a feedback loop. A wearable might flag poor sleep. A lab test might show elevated glucose. A digital health tool might suggest changes to diet or exercise, or follow-up care. Over time, prevention starts to feel less like an annual event and more like a daily habit. The sector implications are broad. In healthcare, more testing may initially actually increase utilization as people follow up on results. But over time, earlier detection could obviously support lower-cost of care and better chronic disease management. That also aligns with value-based care, where providers and payers are rewarded for better outcomes and lower total costs, not just simply more services. In consumer sectors, better health tracking could shape food choices, reduce demand for some indulgent categories, and support products tied to hydration, lower sugar, protein, and functional benefits. Fitness may also benefit as gyms evolve from just workout destinations into broader wellness platforms, with recovery and coaching, and preventive health services layered in. Imaging is another emerging area, as screening shifts from reactive diagnostics toward earlier disease detection. Of course, there is some risk that these health tracking and consumer-driven diagnostics trends could still prove to be a wellness craze rather than the new normal. Out-of-pocket costs, privacy concerns, inconsistent interpretations, and limited repeat testing are all real issues. But consumers are clearly taking more control of their health and increasingly asking, “What can I learn before I get sick?” Thanks for listening. If you enjoy the show, please leave us a review wherever you listen and share Thoughts on the Market with a friend or colleague today.
Most of medicine is built around snapshots. You feel something, you test for it, and by the time you find it, you're already behind. But what if the problem isn't the test—it's how we use it? In this episode, I sit down with physicist and imaging pioneer Dr. Daniel Sodickson, Chief Medical Scientist at Function Health and author of The Future of Seeing. We break down why tools like MRI are shifting from one-time scans to something far more powerful: tracking your health over time. Watch the full conversation on YouTube, or listen wherever you get your podcasts. In this episode, we cover: • Why waiting for symptoms puts you behind—and how to get ahead • What an MRI can reveal about your body that bloodwork can't • How tracking your health over time helps you catch problems sooner • Why having a baseline could change the way you make health decisions • What it means to shift from reacting to disease to actually predicting it When you stop looking at a single result and start looking at patterns, you can catch changes earlier, reduce false alarms, and better predict where your health is headed. View Show Notes From This Episode Get Free Weekly Health Tips from Dr. Hyman https://drhyman.com/pages/picks?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Sign Up for Dr. Hyman's Weekly Longevity Journal https://drhyman.com/pages/longevity?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Join the 10-Day Detox to Reset Your Health https://drhyman.com/pages/10-day-detox Join the Hyman Hive for Expert Support and Real Results https://drhyman.com/pages/hyman-hive This episode is brought to you by BON CHARGE, Maui Nui, Sunlighten, Paleovalley, Fatty15 and BIOptimizers. Head to boncharge.com/hyman and use code HYMAN for 15% off. Go to mauinuivenison.com/hyman to claim your free 6-pack of their Wild Axis Venison Jerky Sticks. Visit sunlighten.com and use code HYMAN to save up to $1600 today! Head to paleovalley.com/hyman to save 15% off your first order today. Head to fatty15.com/HYMAN today and use code HYMAN for 15% off your 90-day subscription Starter Kit. Head to bioptimizers.com/hyman and use promo code HYMAN at checkout to save 15%. (0:00) Introduction and overview of modern medical imaging (3:26) Discussion with Dr. Daniel K. Sodickson begins (3:45) Full body MRIs: Benefits, risks, and the inspiration behind "The Future of Seeing" (7:52) Extending senses and paradigm shifts in imaging technology (14:55) Longitudinal imaging and its benefits (19:17) Future of personalized health data and imaging technology (23:54) Addressing information overload and reducing false positives through AI (28:33) Cost, accessibility, and innovations in imaging techniques (32:00) Vision for ubiquitous and continuous health scanning (33:30) Imaging vs. blood work: Comprehensive health assessment (35:29) Real-life examples and early detection through imaging (39:27) Historical context and real-time health data collection (41:46) Who should get baseline MRIs and scan frequency (47:26) The everywhere scanner: Future implications and cancer detection (52:35) Medical intelligence and transforming health monitoring (57:47) Preventive measures, early detection, and course correction (1:00:30) Medical intelligence labs and the future of healthcare (1:03:32) Future of personal data-driven healthcare and closing remarks
© 2020-2026 Ivy Podcast Discovery LLC
